2014-09-03 21:40:32 UTC

CGH Podcast September 2014: Restarting Infliximab in IBD Patients with Prior Loss of Response

An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflammatory bowel disease patients after a period of discontinuation. Dr. Kuemmerle speaks to an author of the editorial, Dr. Maria T. Abreu of the University of the Miami Miller School of Medicine, Miami, Florida; Plus, summaries of top stories from this month's issue of GI and Hepatology News.

 

 

Yarur AJ, Abreu MT. Back to the Beginning: Restarting Infliximab in Inflammatory Bowel Disease Patients With Prior Loss of Response. Clinical Gastroenterology & Hepatology 2014; September 12(9): 1482-1484
Full Text

 

 

Related article:
Baert F, Drobne D, Gils A, et al. Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy. Clinical Gastroenterology & Hepatology 2014; September 12(9): 1474-1481
Abstract

 

 

Duration: 17.32m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

 

 

More on IBD

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 12, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.